What technical signals does Tenaya Therapeutics (TNYA) have?

Tenaya Therapeutics current technical signals: no active technical signal.

Is Tenaya Therapeutics a cup-and-handle pattern?

No. Tenaya Therapeutics has no valid cup-and-handle signal right now.

What are Tenaya Therapeutics's financials and valuation?

Tenaya Therapeutics's income statement, balance sheet and cash flow are free for the most recent 8 years; the full history is on Pro. PER/PBR, dividend yield and sector valuation bands are free.

Tenaya Therapeutics

TNYA · Nasdaq

$0.6832-1.74%

2026-09-04 close

Tenaya Therapeutics last closed at $0.6832 (-1.74%) on 2026-09-04. Signals today: MACD bullish cross. Listed on Nasdaq; price, financials and dividends update daily after market close.

Loading chart…

No active signal.

New high + volume — the real recordrecord · not a prediction

Last 30 sessions

277 picks

Next-day win rate

44.2%

Avg next-day

-0.28%

vs market

-0.51%p

Every new-high-plus-volume pick we actually published (US market) — not this stock alone.

Trade plan

EntryAccount sizeStopTarget (optional)Risk per trade (%)

Fill entry, stop, account size and risk percent to get a share count. The stop must sit below the entry.

A calculator · not advice or a guarantee

Financials & valuation at a glance

Overall: 건강관리 663/745 · top 89%

Factor composite · relative position in sector

PER — · PBR 1.57 — own-history percentile 27/100 · 32/100

Open self-history band

PER27/100

PBR32/100

Factual information · not investment advice

Past reported results · not investment advice

More — deeper indicators

Financial safety

Reference indicatorAs of 2024

Distress zoneFinancial-metric reference signal

Altman Z'' zoneZ'' -14.07

Distress

Grey

Safe

The marker shows the current Z'' value within the displayed zones.

Altman Z'': -14.07
Beneish M-Score: —
Sloan accrual: -17.20%

부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.

Factual information, not investment advice.

Earnings quality · Piotroski F-Score

1/9Weak

Piotroski measures year-over-year financial improvement, not absolute quality.

Financial improvement score1/9

Profitability

Positive ROANot passed
Positive OCFNot passed
Improving ΔROANot passed
Accruals (OCF > net income)Pass

Leverage & liquidity

Lower debtNot passed
Higher current ratioNot passed
No new sharesNot passed

Efficiency

Higher gross marginNot passed
Higher asset turnoverNot passed

Calculation note: F7(신주)은 equity/asset 유지로 근사

Already-stable companies may score lower when year-over-year improvement is limited.

Factual information, not investment advice.

Connections

AI-extracted related companies · for reference

Competitors

NovartisNovo NordiskBristol Myers SquibbPrice comovement r=0.08 (1 year)AmgenPrice comovement r=0.16 (1 year)Eli LillyPrice comovement r=0.11 (1 year)PfizerPrice comovement r=0.12 (1 year)Vertex PharmaceuticalsPrice comovement r=0.10 (1 year)Bluebird BioSpark TherapeuticsRegeneron PharmaceuticalsPrice comovement r=0.13 (1 year)

Same theme

Fierce BiotechBeam TherapeuticsPrice comovement r=0.29 (1 year)Intellia TherapeuticsPrice comovement r=0.28 (1 year)CRISPR TherapeuticsPrice comovement r=0.29 (1 year)

🔗 See in the full market map →

Recent filings

Filings for overseas stocks are on the way. For now we cover Korean stocks only.

About Tenaya Therapeutics

What technical signals does Tenaya Therapeutics (TNYA) have?: Tenaya Therapeutics current technical signals: no active technical signal.
Is Tenaya Therapeutics a cup-and-handle pattern?: No. Tenaya Therapeutics has no valid cup-and-handle signal right now.
What are Tenaya Therapeutics's financials and valuation?: Tenaya Therapeutics's income statement, balance sheet and cash flow are free for the most recent 8 years; the full history is on Pro. PER/PBR, dividend yield and sector valuation bands are free.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Quantus Signal · live data · not investment advice · Privacy Policy